ConductScience.org, home

Paper49293

Modulation of human neutrophil polymorphonuclear leucocyte migration by human plasma alpha-globulin inhibitors and synthetic esterase inhibitors.

Goetzl EJ. Immunology, 1975. Cited by 79 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Modulation of human neutrophil polymorphonuclear leucocyte migration by human plasma alpha-globulin inhibitors and synthetic esterase inhibitors. Papers, record 49293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/49293

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modulation of human neutrophil polymorphonuclear leucocyte migration by human plasma alpha-globulin inhibitors and synthetic esterase inhibitors.
PubMed
Journal
Immunology
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
2.94
iCite
Revised in PubMed
2018-11-13
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goetzl EJE J

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alpha-GlobulinsMajor topic
Cell MovementMajor topic
EsterasesMajor topic
MacroglobulinsMajor topic
NeutrophilsMajor topic
alpha 1-AntitrypsinMajor topic
Carbon Dioxide
Cell Migration Inhibition
Chemotaxis
Complement C3
Complement C5
Glucose
Humans
Tosyllysine Chloromethyl Ketone
Tosylphenylalanyl Chloromethyl Ketone

Source PubMed

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,201,266Interrelationships between the human alveolar macrophage and alpha-1-antitrypsin.J Clin Invest1973https://conductscience.org/library/papers/4201266PubMed
24,217,768A method for assessing the in vitro chemotactic response of neutrophils utilizing 51cr-labeled human leukocytes.Immunol Commun1972https://conductscience.org/library/papers/4217768PubMed
34,269,559Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure.J Exp Med1973https://conductscience.org/library/papers/4269559PubMed
44,273,024Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid.J Clin Invest1974https://conductscience.org/library/papers/4273024PubMed
54,345,523Neutrophil proteases in inflammation.Annu Rev Med1972https://conductscience.org/library/papers/4345523PubMed
64,547,125A neutrophil-dependent pathway for the generation of a neutral peptide mediator: partial characterization of components and control by alpha-1-antitrypsin.J Exp Med1974https://conductscience.org/library/papers/4547125PubMed
74,632,673The purification of human serum 1 -antitrypsin by affinity chromatography on concanavalin A.Biochem Biophys Res Commun1973https://conductscience.org/library/papers/4632673PubMed
84,641,855A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.J Exp Med1972https://conductscience.org/library/papers/4641855PubMed
94,703,226Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.J Clin Invest1973https://conductscience.org/library/papers/4703226PubMed
104,908,090Selective chemical modification of proteins.Physiol Rev1970https://conductscience.org/library/papers/4908090PubMed
114,956,917Immunochemical quantitation of antigens by single radial immunodiffusion.Immunochemistry1965https://conductscience.org/library/papers/4956917PubMed
124,972,183The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis.J Immunol1968https://conductscience.org/library/papers/4972183PubMed
134,986,160Rapid detection of Australia antigen by counterimmunoelectrophoresis.J Immunol1970https://conductscience.org/library/papers/4986160PubMed
145,477,337Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator.J Lab Clin Med1970https://conductscience.org/library/papers/5477337PubMed
155,530,772Biochemical demonstration of the activatable esterase of the rabbit netrophil involved in the chemotactic response.J Immunol1970https://conductscience.org/library/papers/5530772PubMed
165,642,465The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.J Exp Med1968https://conductscience.org/library/papers/5642465PubMed
1711,344,574Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors.J Clin Invest1974https://conductscience.org/library/papers/11344574PubMed
181,167,560Effects of human C 1 inhibitor on complement-mediated human leukocyte chemotaxis.J Immunol1975https://conductscience.org/library/papers/1167560PubMed
194,122,174Plasma inhibitors of the components of the fibrinolytic pathway in man.J Clin Invest1973https://conductscience.org/library/papers/4122174PubMed
204,166,651Alpha-1-antitrypsin, an inhibitor for thrombin and plasmin.Clin Chim Acta1967https://conductscience.org/library/papers/4166651PubMed

See all 22 references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
8,543,371Inhibition of neutrophil chemotaxis by protease inhibitors. Differential effect of inhibitors of serine and thiol proteases.Inflammation1995https://conductscience.org/library/papers/8543371PubMed
7,399,690Effects of human complement component 1 inactivator on neutrophil chemotaxis and chemotactic deactivation.Infect Immun1980https://conductscience.org/library/papers/7399690PubMed
6,442,538Influence of the anti-inflammatory serine esterase inhibitor gabexate mesilate (Foy) on aggregation, locomotion and adhesion of polymorphonuclear leukocytes.Agents Actions1984https://conductscience.org/library/papers/6442538PubMed
6,194,105Effect of modified alpha 2macroglobulin on leucocyte locomotion and chemotaxis.Immunology1983https://conductscience.org/library/papers/6194105PubMed
2,989,172Membrane endopeptidases of human neutrophil.Inflammation1985https://conductscience.org/library/papers/2989172PubMed
2,361,732Neutrophil chemotactic activity is modulated by human cystatin C, an inhibitor of cysteine proteases.Inflammation1990https://conductscience.org/library/papers/2361732PubMed
2,024,711Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.Am J Pathol1991https://conductscience.org/library/papers/2024711PubMed
1,065,899Role of a peptidase in phagocyte chemotaxis.Proc Natl Acad Sci U S A1976https://conductscience.org/library/papers/1065899PubMed
1,003,098Structural determinants of the eosinophil: chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxis.J Exp Med1976https://conductscience.org/library/papers/1003098PubMed
830,662Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid.J Clin Invest1977https://conductscience.org/library/papers/830662PubMed
649,652Chemotaxis by polymorphonuclear leukocytes.J Cell Biol1978https://conductscience.org/library/papers/649652PubMed
641,154Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung.J Clin Invest1978https://conductscience.org/library/papers/641154PubMed
475,975Inhibitory effect of pregnancy on the migration of the inflammatory cells: a quantitative histological study.Br J Exp Pathol1979https://conductscience.org/library/papers/475975PubMed
264,125Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors.J Cell Biol1977https://conductscience.org/library/papers/264125PubMed

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
A2M2PubTator's text mininghttps://conductscience.org/library/genes/2NCBI Gene
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene
C5727PubTator's text mininghttps://conductscience.org/library/genes/727NCBI Gene
C5AR1728PubTator's text mininghttps://conductscience.org/library/genes/728NCBI Gene
SERPINA15,265PubTator's text mininghttps://conductscience.org/library/genes/5265NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/49293

GET https://conductscience.org/api/papers/v1/49293/references?page=2